0001491487
false
00000
0001491487
2023-07-10
2023-07-10
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND
EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
July 10, 2023
TAKUNG ART CO., LTD
(Exact name of Registrant as specified in its
charter)
Delaware |
|
001-38036 |
|
26-4731758 |
(State or other jurisdiction
of Incorporation) |
|
(Commission
File No.) |
|
(IRS Employer
Identification No.) |
Office
Q 11th Floor, Kings
Wing Plaza 2
No. 1 Kwan Street, Sha Tin, New Territories,
Hong Kong
(Address of Principal Executive Offices)
Registrant’s telephone number: +8613020144962
Room 709 Tower 2, Admiralty Centre,
18 Harcourt Road, Admiralty, Hong Kong
(Former name or former address, if changed since
last report)
Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see
General Instruction A.2. below):
☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
|
Trading Symbol(s) |
|
Name of each exchange on which registered |
Common Stock, par value $0.001 per share |
|
TKAT |
|
NYSE American |
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth
company ☐
If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.02 |
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers |
On July
10, 2023, Mr. Jianguang Qian tendered his resignation as the Chief Financial Officer of Takung Art
Co., Ltd. (the “Company”), effective immediately. Mr. Qian’s decision to resign was not the result of any disagreements
with the Company on any matter related to the operations, policies, or practices of the Company.
On the same
date, the nominating committee of the board of directors (the “Board”) of the Company appointed Mr. Yaobin Wang as
the new Chief Financial Officer, effective immediately, to fill in the vacancy resulting from the resignation of Mr. Qian. In connection
with Mr. Wang’s appointment, the Company and Mr. Wang entered into an employment agreement, dated July 10, 2023 (the “CFO
Employment Agreement”), pursuant to which Mr. Wang will receive an annual base salary of $60,000 and discretionary share compensation
for his services as Chief Financial Officer. His term of employment, which began July 10, 2023, is for one year, with the first three
months being his probationary period. His employment may be terminated at any time during this probationary period and thereafter upon
one month’s written notice. Mr. Wang may terminate his employment at any time for any reason or no reason upon three month’s
advance written notice.
Mr. Yaobin Wang has served as the Finance Director
& Operation Data Director of Lvmama.com since August 2018. From June 2017 to July 2018, Mr. Wang served as the Director and CFO of
SunMoon Food Company Limited (SGX: AAJ). Mr. Wang served as an Investment Director of Yiguo Group from June 2017 to July 2018 and prior
to that as Finance Director from April 2015 to June 2017. Mr. Wang received his bachelor’s degree in International Trade & Economy
from Shanghai Jiao Tong University in 2008. Mr. Wang is a certified public accountant in China (CICPA) and the United States (AICPA).
There is no family relationship between Mr. Wang
and any of our other officers and directors. Except for the employment agreement described above, Mr. Wang has not had any transaction
with the Company since the beginning of our last fiscal year.
The foregoing description of the principal terms
of the CFO Employment Agreement is a general description only, does not purport to be complete, and is qualified in its entirety by reference
to the terms of the CFO Employment Agreement attached hereto as Exhibit 10.1, which is incorporated herein by this reference.
Item 9.01. |
Financial Statements and Exhibits. |
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
Date: July 10, 2023
|
Takung Art Co., Ltd |
|
|
|
/s/ Kuangtao Wang |
|
Name: |
Kuangtao Wang |
|
Title: |
Chief Executive Officer |
2
Exhibit 10.1
TAKUNG
ART CO., LTD
Executive
Employment Agreement
This EXECUTIVE EMPLOYMENT AGREEMENT (the “Agreement”),
entered into as of July 10, 2023, by and between Takung Art Co., Ltd., a Delaware corporation (the “Company”) and Yaobin Wang
(the “Executive”). The Company and Executive are collectively referred to herein as the “Parties.” This Agreement
automatically shall supersede any agreement between the Company and Executive concerning Executive’s employment by the Company.
RECITALS
A. The Company desires to
employ the Executive as its Chief Financial Officer (CFO), and to assure itself of the services of the Executive for the Initial Period
and Extended Period (each as defined below).
B. The Executive desires to
be employed by the Company as its CFO for the Initial Period and Extended Period and upon the terms and conditions of this Agreement.
C. Executive agrees to use
his best efforts, and apply his skill and experience, to the proper performance of his duties hereunder and to the business and affairs
of the Company. Executive agrees to serve the Company faithfully, diligently and to the best of his ability.
AGREEMENT
ACCORDINGLY, the Parties agree
as follows:
1. Term of Employment.
The Company shall employ the Executive to render services to the Company in the position and with the duties and responsibilities
described in Section 2 for a period of three (3) months starting from the date of this Agreement (the “Initial Period”),
which period shall be automatically extended for an additional nine (9) months (the “Extended Period ”), unless the Company
provides notice to the Executive of its election not to extend the period prior to the expiration of the Initial Period, or unless the
Initial Period or Extended Period, as applicable, is terminated sooner in accordance with Sections 4 or 5 below or extended upon mutual
agreement of the Parties.
2. Position, Duties, Responsibilities.
2.1 Position. The Executive
shall render services to the Company in the positions of CFO and shall perform all services appropriate to such position. The Executive’s
principal place of employment shall be at any location mutually acceptable to the board of directors of the Company and the Executive.
The Executive shall devote his best efforts to the performance of his duties. The Executive shall report to the board of directors of
the Company.
2.2 Execution of Other
Employment Agreements. The Executive shall upon request of the Company execute an employment agreement with any direct or indirect
subsidiary of the Company (in each case, a “Subsidiary Employment Agreements”) in accordance with Hong Kong or China
laws and regulations, in the form substantially identical to this Agreement except for adjustments or alterations required to comply with
the relevant laws and regulations of the Hong Kong or China as the case may be.
3. Compensation and Holiday.
In consideration of the services to be rendered under this Agreement, the Executive shall be entitled to the following:
3.1 Base Salary. The
Company shall pay the Executive a “Base Salary” of USD5,000 per month, subject to adjustment in accordance with Section
3.2 below. The Base Salary shall be paid in accordance with the Company’s regularly established payroll practices.
3.2 Salary Adjustment.
The Executive’s Base Salary will be reviewed from time to time in accordance with the established procedures of the Company for adjusting
salaries for similarly situated employees and may be adjusted in the sole discretion of the Company.
3.3 Benefits. The
Executive shall be eligible to participate in the benefits made generally available by the Company to similarly-situated executives,
in accordance with the benefit plans established by the Company (including the Company’s Equity Incentive Plan), and as may be
amended from time to time in the Company’s sole discretion. Nothing contained in this Article shall affect or in any way limit
Executive’s rights as an executive employee of the Company to participate in any profit sharing plan, supplemental compensation
arrangements or any other fringe benefits offered by the Company to its employees as set forth in the Company’s employee handbook,
and compensation received by Executive hereunder shall be in addition to the foregoing except that the severance benefits set forth in
this Agreement shall be exclusive.
3.4 Bonus. The Executive shall not be entitled to any bonus unless otherwise approved by the
board of directors of the Company in its sole discretion.
3.5 Holidays. The Executive
shall be entitled to applicable statutory public holidays in each full calendar year. If the Executive’s employment commences or terminates
part way through a calendar year, his entitlement to holidays will be assessed on a pro-rata basis in accordance with the Company’s holiday
policy, as it may change from time to time.
4. Termination By Company.
4.1 Termination for Cause.
For purposes of this Agreement, “For Cause” shall mean the occurrence of any of the following, subject only to any statutory
requirement of any applicable law: (i) the failure of the Executive to properly carry out his duties after notice by the Company of the
failure to do so and a reasonable opportunity for the Executive to correct the same within a reasonable period specified by the Company;
(ii) any breach by the Executive of one or more provisions of any written agreement with, or written policies of, the Company or his fiduciary
duties to the Company likely to cause material harm to the Company and its affiliates, at the Company’s reasonable discretion, or (iii)
any theft, fraud, dishonesty or serious misconduct by the Executive involving his duties or the property, business, reputation or affairs
of the Company and its affiliates. The Company may terminate the Executive’s employment For Cause at any time, without any advance notice
or payment in lieu of notice. The Company shall pay to the Executive all compensation prescribed under Section 3 hereof to which the Executive
is entitled up through the date of termination, subject to any other rights or remedies of the Company under law, and thereafter all obligations
of the Company under this Agreement shall cease.
4.2 By Disability.
In the event Executive shall, by reason of illness or other incapacity, become unable to perform the services agreed upon herein (“Disability”
or “Disabled”), the Company shall continue to compensate Executive for six (6) months commencing from the date of such Disability
at his base monthly salary less any amounts actually received by Executive from the disability insurance policies carried by the Company
for the benefit of Executive pursuant to Section 3. “Disability” shall mean if, as a result of Executive’s incapacity due to
physical or mental illness, Executive shall have been absent from the full-time performance of Executive’s duties with the Company for
three (3) consecutive months, and within thirty (30) days after written notice of termination is given Executive shall not have returned
to the full-time performance of Executive’s duties. The determination of Disability will be established by the Company’s benefit
provider. The determination of such benefit provider shall be made in writing to the Company and Executive and shall be final and conclusive
for purposes of this Agreement.
4.3 Other Termination by
Company. In addition to Sections 4.1 through 4.2, the Company may at any time terminate the employment of the Executive without cause:
(i) at any time during the Initial Period, in which case the Executive will not be eligible to receive any severance; or (ii) by giving
one (1) month written notice to the Executive during the Extended Period, in which case the Executive will be eligible to receive an amount
equal to one (1) month of the then-current Base Salary of the Executive payable in the form of salary continuation (the “Severance”).
The Executive’s eligibility for Severance is conditioned on the Executive having first signed a Termination Certificate in the form attached
as Exhibit A. The Executive shall not be entitled to any Severance payments if the Executive’s employment is terminated For Cause,
by death or by Disability (as provided above) or if the Executive’s employment is terminated by the Executive for any reason other than
Good Reason, as defined below.
5. Termination By Executive.
5.1 Termination by Executive
other than for Good Reason. The Executive may terminate employment with the Company at any time for any reason or no reason at all,
upon three (3) months’ advance written notice. During such notice period the Executive shall continue to diligently perform all of the
Executive’s duties hereunder. The Company shall have the option, in its sole discretion, to make the Executive’s termination effective
at any time prior to the end of such notice period as long as the Company pays the Executive all compensation under Section 3 hereof to
which the Executive is entitled up through the actual termination date. Thereafter all obligations of the Company shall cease. Unless
the Executive terminates his employment for Good Reason, as provided in Section 5.2, no Severance or other separation benefits shall be
paid to the Executive.
5.2
Termination for Good Reason. The Executive’s termination shall be for Good Reason (as defined below) if the Executive provides
written notice to the Company of the Good Reason within ten (10) days of the event constituting Good Reason and provides the Company with
a period of ten (10) days to cure the Good Reason and the Company fails to cure the Good Reason within that period. For purposes of this
Agreement, “Good Reason” shall mean, without the Executive’s express written consent, the occurrence of any of the following
circumstances: (a) The assignment to Executive of any duties inconsistent with Executive’s status as an executive officer of the
Company or a substantial adverse alteration in the nature or status of Executive’s responsibilities from those in effect upon the
date hereof; (b) A reduction by the Company by more than twenty percent (20%) in Executive’s Base Salary as in effect on the date
hereof; (c) The failure by the Company, without Executive’s consent, to pay to Executive any portion of Executive’s compensation
due hereunder more than twice in any 12 month period except pursuant to an across-the-board compensation deferral similarly affecting
all executives of the Company; (d) The failure by the Company to continue to provide Executive with benefits or arrangements (including,
without limitation, income tax services, car allowances, and other fringe benefits) at least as favorable to those enjoyed by Executive
upon the start of employment hereunder, the taking of any action by the Company which would directly or indirectly materially reduce any
of such benefits or deprive Executive of any material fringe benefit enjoyed by Executive upon the start of employment hereunder. Executive’s
continued employment shall not constitute consent to, or a waiver of rights with respect to, any circumstance constituting Good Reason
hereunder. Upon occurrence of any of the foregoing events which Executive believes constitutes “Good Reason,” Executive must
notify the Company in writing within ten (10) days and give the Company ten (10) days to cure or correct the alleged action or failure.
After the expiration of twenty (20) days, Executive may quit for “Good Reason” by giving written notice within an additional
fourteen (14) days.
6. Termination Obligations.
The Executive agrees that
on or before termination of employment, she will promptly return to the Company all documents and materials of any nature pertaining to
his work with the Company, including all originals and copies of all or any part of any Proprietary Information or Inventions (as defined
below) along with any and all equipment and other tangible and intangible property of the Company. The Executive agrees not to retain
any documents or materials or copies thereof containing any Proprietary Information or Inventions.
The Executive further agrees
that: (i) all representations, warranties, and obligations under Articles 6, 7, 8, 9, 10, 11, 12, 14.1, 14.2, 14.3 and 14.4 contained
in this Agreement shall survive the termination of the Initial Period and Extended Period, as applicable; (ii) the Executive’s representations,
warranties and obligations under Articles 6, 7, 8, 9, 10, 11, 12, 14.1, 14.2, 14.3 and 14.4 shall also survive the expiration of this
Agreement; and (iii) following any termination of the Initial Period or Extended Period, as applicable, the Executive shall fully cooperate
with the Company in all matters relating to his continuing obligations under this Agreement, including but not limited to the winding
up of pending work on behalf of the Company, the orderly transfer of work to the other employees of the Company, and the defense of any
action brought by any third party against the Company that relates in any way to the Executive’s acts or omissions while employed by the
Company. The Executive also agrees to sign and deliver the Termination Certificate attached hereto as Exhibit A prior to his termination
of employment with the Company.
7. Post-Termination Activity.
7.1 No Use of Proprietary
Information. The Executive acknowledges that the pursuit of the activities forbidden by this subsection would necessarily involve
the use or disclosure of Proprietary Information in breach of this Agreement, but that proof of such a breach would be extremely difficult.
To forestall such disclosure, use, and breach, and in consideration of the employment under this Agreement, the Executive also agrees
that while employed by the Company, and for a period of six (6) months after termination of the Executive’s employment, the Executive
shall not, directly or indirectly:
(i) divert or attempt to divert
from the Company or any Affiliate (“Affiliate” shall mean any person or entity that directly, or indirectly through one
or more intermediaries, controls, or is controlled by, or is under common control with such entity). For the purposes of this definition
“control” means the possession, directly or indirectly, of the power to direct or cause the direction of the management
and policies of a person, whether through the ownership of voting securities, by contract or otherwise, and includes (a) ownership directly
or indirectly of 50% or more of the shares in issue or other equity interests of such person, (b) possession directly or indirectly of
50% or more of the voting power of such person or (c) the power directly or indirectly to appoint a majority of the members of the board
of directors or similar governing body of such person, and the terms “controlling” and “controlled”
have meanings correlative to the foregoing) any business of any kind in which it is engaged, including, without limitation, soliciting
business from or performing services for, any persons, company or other entity which at any time during the Executive’s employment by
the Company is a client, supplier, or customer of the Company or prospective client, supplier, or customer of the Company if such business
or services are of the same general character as those engaged in or performed by the Company;
(ii) solicit or otherwise
induce any person to terminate his employment or consulting relationship with the Company or any Affiliate; or
(iii) engage, invest or assist
in any business activity that directly or indirectly competes with any business plan of the Company or any Affiliate.
In addition, because the Executive
acknowledges the difficulty of establishing when any intellectual property, invention, or proprietary information is first conceived or
developed by the Executive, or whether it results from access to Proprietary Information or the Company equipment, supplies, facilities,
or data, the Executive agrees that any intellectual property, invention, or proprietary information shall be reported to the Company and,
unless proven otherwise to the reasonable satisfaction of the Company, shall be presumed to be an Invention (as defined below) for the
purpose of this Agreement and shall be subject to all terms and conditions hereof, if reduced to practice by the Executive or with the
aid of the Executive within six (6) months after termination of the Initial Period or Extended Period, as applicable.
7.2 No Competition.
Notwithstanding Section 7.1 above, while employed by the Company and for a period of six (6) months after the termination of the Executive’s
employment with the Company for any reason whatsoever, the Executive shall not, directly or indirectly, as an executive, employer, employee,
consultant, agent, principal, partner, manager, stockholder, officer, director, or in any other individual or representative capacity,
engage, aid, counsel or participate in any business within Hong Kong and the People’s Republic of China that is competitive with
the business of the Company or any Affiliate. Notwithstanding the foregoing, the Executive may own less than one percent (1%) of any class
of stock or security of any corporation listed on an internationally recognized securities exchange which competes with the Company.
7.3 Enforceability.
The covenants of this Article 7 are several and separate, and the unenforceability of any specific covenant shall not affect the provisions
of any other covenant. If any provision of this Article 7 relating to the time period or geographic area of the restrictive covenants
shall be declared by a court of competent jurisdiction to exceed the maximum time period or geographic area, as applicable, that such
court deems reasonable and enforceable, then this Agreement shall automatically be considered to have been amended and revised to reflect
the maximum time period or geographic area that such court deems enforceable.
7.4 Independent Covenants.
All of the covenants in this Article 7 shall be construed as an agreement independent of any other provision in this Agreement, and the
existence of any claim or cause of action of the Executive against the Company or any of its Affiliates, whether predicated on this Agreement
or otherwise, shall not constitute a defense to the enforcement by the Company of such covenants.
8. Proprietary Information.
The Executive agrees during
his employment with the Company and within three (3) years thereafter, to hold in strictest confidence and trust, and not to use or disclose
to any person, firm or corporation any Proprietary Information without the prior written consent of the Company, except as necessary in
carrying out his duties as an employee of the Company for the benefit of the Company. “Proprietary Information” means
any information of a proprietary, confidential or secret nature that may be disclosed to the Executive that relates to the business of
the Company or of any parent, subsidiary, Affiliate, customer or supplier of the Company or any other party with whom the Company agrees
to hold information of such party in confidence (“Relevant Parties”). Such Proprietary Information includes, but is not
limited to, Inventions (as defined below), research, product plans, products, services, business strategies, personnel information, customer
lists, customers, markets, technical information, forecasts, marketing, finances or other business information of the Company and its
Affiliates. This information shall remain confidential whether it was disclosed to the Executive either directly or indirectly in writing,
orally or by drawings or observation. The Executive understands that Proprietary Information does not include any of the foregoing items
which has become publicly known and made generally available through no wrongful act of the Executive or others who were under confidentiality
obligations as to the items involved.
9. Former Employer Information.
The Executive agrees that
she will not, during his employment with the Company, improperly use or disclose any proprietary information or trade secrets, or bring
onto the premises of the Company any unpublished document or proprietary information belonging to any former or concurrent employer or
other person or entity (excluding any direct or indirect subsidiary of the Company).
10. Third Party Information.
The Executive recognizes that
the Company has received and in the future will receive confidential or proprietary information from third parties. The Executive agrees
to hold all such confidential or proprietary information in the strictest confidence and trust, and not to disclose it to any person,
firm or corporation or to use it except as necessary in carrying out his work for the Company consistent with the Company’s agreement
with such third party.
11. No Conflict.
The Executive represents and
warrants that the Executive’s execution of this Agreement, his employment with the Company, and the performance of his proposed duties
under this Agreement shall not violate any obligations she may have to any former employer or other party, including any obligations with
respect to proprietary or confidential information or intellectual property rights of such party or require the consent or approval of
any third party.
12. Inventions.
12.1 Inventions Retained
and Licensed. The Executive has attached, as Exhibit B, a list describing all inventions, original works of authorship, developments,
improvements, and trade secrets which were made by the Executive prior to the Executive’s employment with the Company (“Prior
Inventions”), which belong to the Executive, and which relate to the Company’s actual and/or proposed business, products or research
and development. If, in the course of his employment with the Company, the Executive incorporates into a Company product, process or machine
a Prior Invention owned by the Executive or in which the Executive has an interest, the Company is hereby granted and shall have a non-exclusive,
royalty-free, irrevocable, perpetual, worldwide license to make, have made, modify, use and sell such Prior Invention as part of or in
connection with such product, process or machine.
12.2 Assignment of Inventions.
The Executive agrees that she will promptly make full written disclosure to the Company, will hold in trust for the sole right and benefit
of the Company, and hereby irrevocably assigns to the Company, or its designee, all the Executive’s right, title, and interest in and
to any and all inventions, original works of authorship, developments, concepts, improvements, designs, drawings, discoveries, ideas,
formulas, processes, compositions of matter, software, databases, mask works, computer programs (including all source codes) and related
documentation, algorithms, engineering and reverse engineering, technology, hardware configuration information, logos, trade names, trademarks,
patents, patent applications, copyrights, trade secrets or know-how, which the Executive may solely or jointly conceive or develop or
reduce to practice, or cause to be conceived or developed or reduced to practice (“Inventions”), while the Executive
is employed by the Company. The Executive further acknowledges that all original works of authorship which are made by the Executive (solely
or jointly with others) within the scope of and during his employment with the Company and which are protectable by copyright are “works
made for hire,” as that term is defined in the United States Copyright Act and that the Company will be considered the author
and owner of such works. The Executive understands and agrees that the decision whether or not to commercialize or market any Invention
developed by the Executive solely or jointly with others is within the Company’s sole discretion and for the Company’s sole benefit and
that no royalty will be due to the Executive as a result of the Company’s efforts to commercialize or market any such Invention.
12.3 Waiver of Moral Rights. To the utmost
extent legally permitted, the Executive also hereby forever waives and agrees never to assert any and all Moral Rights (as defined below)
he may have in or with respect to any Invention, even after termination of his work on behalf of the Company. “Moral Rights”
mean any rights to claim authorship of an Invention to object to or prevent the modification of any Invention, or to withdraw from circulation
or control the publication or distribution of any Invention, and any similar right, existing under judicial or statutory law of any country
in the world, or under any treaty, regardless of whether or not such right is denominated or generally referred to as a “moral
right.”
12.4 Maintenance of Records. The Executive
agrees to keep and maintain adequate and current written records of all Inventions made by the Executive (solely or jointly with others)
during the Executive’s employment with the Company. The records will be in the form of notes, sketches, drawings, and any other format
that may be specified by the Company. The records will be provided to, and remain the sole property of, the Company at all times.
12.5 Patent and Copyright
Registrations. The Executive agrees to assist the Company, or its designee, at the Company’s expense, in every proper way, to secure
the Company’s rights in the Inventions and any copyrights, patents, mask work rights, trade secret rights or other intellectual property
rights relating thereto in any and all countries. The Executive will disclose to the Company all pertinent information and data which
the Company deems necessary for the execution of all applications, specifications, oaths, assignments and execute all instruments necessary
to apply for and obtain such rights and in order to assign and convey to the Company, its successors, assigns, and nominees, the sole
and exclusive right, title and interest in and to such Inventions, and any copyrights, patents, mask work rights, or other intellectual
property rights relating thereto. The Executive further agrees that the Executive’s obligation to execute or cause to be executed, when
it is in the Executive’s power to do so, any such instrument or papers shall continue after the termination of this Agreement. If
the Company is unable, because of the Executive’s mental or physical incapacity or for any other reason, to secure his signature to apply
for or to pursue any application for any patents or copyright registrations covering the Inventions assigned to the Company as above,
then the Executive hereby irrevocably designates and appoints the Company and its duly authorized officers and agents as his agent and
attorney in fact, to act for and in the Executive’s behalf and stead to execute and file any such applications and to do all other lawfully
permitted acts to further the prosecution and issuance of letters, patent or copyright registrations thereon with the same legal force
and effect as if executed by the Executive.
13. Alternative Dispute
Resolution.
Except with respect to any
proceeding brought under Section 7 hereof, the Company and Executive mutually agree that any controversy or claim arising out of or relating
to this Agreement or the breach thereof, or any other dispute between the parties, shall be submitted to mediation before a mutually agreeable
mediator, which cost is to be borne equally by the parties hereto. In the event the Parties fail to agree on a mediator, or mediation
is unsuccessful in resolving the claim or controversy within one (1) month after the commencement of mediation, such claim or controversy
shall be resolved by arbitration in Hong Kong. Any dispute, controversy, difference or claim arising out of or relating to this Agreement,
including the existence, validity, interpretation, performance, breach or termination thereof or any dispute regarding non-contractual
obligations arising out of or relating to it shall be referred to and finally resolved by arbitration administered by the Hong Kong International
Arbitration Centre (HKIAC) under the UNCITRAL Arbitration Rules in force when the Notice of Arbitration is submitted , as modified by
the HKIAC Procedures for the Administration of International Arbitration. The law of this arbitration clause shall be Hong Kong law. The
seat of arbitration shall be in Hong Kong. The number of arbitrators shall be one. The arbitration proceedings shall be conducted in English.
14. Miscellaneous.
14.1 Continuing Obligations.
The obligations in this Agreement will continue in the event that the Executive is hired, renders services to or for the benefit of or
is otherwise retained at any time by any present or future Affiliates of the Company. Any reference to the Company in this Agreement will
include such Affiliates. Upon the expiration or termination for any reason whatsoever of this Agreement, the Executive shall forthwith
resign from any employment of office with an Affiliate of the Company unless the board of directors of the Company requests otherwise.
14.2 Notification.
The Executive hereby authorizes the Company to notify his actual or future employers of the terms of this Agreement and his responsibilities
hereunder.
14.3 Name and Likeness
Rights. The Executive hereby authorizes the Company to use, reuse, and to grant others the right to use and reuse, his name, photograph,
likeness (including caricature), voice, and biographical information, and any reproduction or simulation thereof, in any media now known
or hereafter developed (including but not limited to film, video and digital or other electronic media), both during and after his employment,
for whatever purposes the Company deems necessary.
14.4 Injunctive Relief.
The Executive understands that in the event of a breach or threatened breach of this Agreement by her, the Company may suffer irreparable
harm and will therefore be entitled to injunctive relief to enforce this Agreement.
14.5 Entire Agreement.
This Agreement, including the exhibits attached hereto, is intended to be the final, complete, and exclusive statement regarding their
subject matter, except for other agreements specifically referenced herein. Unless otherwise specifically provided for herein, this Agreement
supersedes all other prior and contemporaneous agreements and statements pertaining to this subject matter, and may not be contradicted
by evidence of any prior or contemporaneous statements or agreements. To the extent that the practices, policies, or procedures of the
Company, now or in the future, apply to the Executive and are inconsistent with the terms of this Agreement, the provisions of this Agreement
shall control.
14.6 Intentionally Ommitted.
14.7 Amendments, Renewals
and Waivers. This Agreement may not be modified, amended, renewed or terminated except by an instrument in writing, signed by the
Executive and by a duly authorized representative of the Company other than the Executive. No failure to exercise and no delay in exercising
any right, remedy, or power under this Agreement shall operate as a waiver thereof, nor shall any single or partial exercise of any right,
remedy, or power under this Agreement preclude any other or further exercise thereof, or the exercise of any other right, remedy, or power
provided herein or by law or in equity.
14.8 Assignment; Successors
and Assigns. The Executive agrees that she will not assign, sell, transfer, delegate or otherwise dispose of, whether voluntarily
or involuntarily, or by operation of law, any rights or obligations under this Agreement, nor shall the Executive’s rights be subject
to encumbrance or the claims of creditors. Any purported assignment, transfer, or delegation shall be null and void. Nothing in this Agreement
shall prevent the consolidation of the Company with, or its merger into, any other corporation, or the sale by the Company of all or substantially
all of its properties or assets, or the assignment by the Company of this Agreement and the performance of its obligations hereunder to
any successor in interest. In the event of a change in ownership or control of the Company, the terms of this Agreement will remain in
effect and shall be binding upon any successor in interest. Notwithstanding and subject to the foregoing, this Agreement shall be binding
upon and shall inure to the benefit of the parties and their respective heirs, legal representatives, successors, and permitted assigns,
and shall not benefit any person or entity other than those enumerated above.
14.9 Indemnification.
The Company shall indemnify the Executive, to the maximum extent permitted by applicable law, against all costs, charges and expenses
incurred or sustained by the Executive in connection with any action, suit or proceeding to which she may be made a party by reason of
being an officer, director or employee of the Company or of any subsidiary or affiliate of the Company or any other corporation for which
the Executive serves in good faith as an officer, director, or employee. The Company will cover Executive under its directors and officers
liability insurance in the same amount and to the same extent as the Company covers its other officers and directors.
14.10 Notices. All
notices and other communications given or made pursuant hereto shall be in writing and shall be deemed to have been duly given or made
as of the date delivered or mailed if delivered personally or by nationally recognized courier or mailed by registered mail (postage prepaid,
return receipt requested) or by telecopy to the parties at the following addresses (or at such other address for a party as shall be specified
by like notice, except that notices of changes of address shall be effective upon receipt):
|
To: |
Company |
|
Contact Address: |
|
|
Attention: |
|
|
To: |
Executive |
|
Contact Address: |
|
|
Attention: |
|
14.11 Waiver of Immunity.
To the extent that any Party (including its assignees of any such rights or obligations hereunder) may be entitled, in any jurisdiction,
to claim for itself (or himself or herself) or its revenues or assets or properties, immunity from service of process, suit, the jurisdiction
of any court, an interlocutory order or injunction or the enforcement of the same against its property in such court, attachment prior
to judgment, attachment in aid of execution of an arbitral award or judgment (interlocutory or final) or any other legal process, and
to the extent that, in any such jurisdiction there may be attributed such immunity (whether claimed or not), such Party hereby irrevocably
waives such immunity.
14.12 Severability; Enforcement.
If any provision of this Agreement, or its application to any person, place, or circumstance, is held by an arbitrator or a court of competent
jurisdiction to be invalid, unenforceable, or void, such provision shall be enforced (by blue-penciling or otherwise) to the maximum extent
permissible under applicable law, and the remainder of this Agreement and such provision as applied to other persons, places, and circumstances
shall remain in full force and effect.
14.13 Governing Law.
This Agreement shall in all respects be construed and enforced in accordance with and governed by the laws of Hong Kong, without regard
to principles of conflict of laws.
14.14 Interpretation.
This Agreement shall be construed as a whole, according to its fair meaning, and not in favor of or against any party. Sections and section
headings contained in this Agreement are for reference purposes only, and shall not affect in any manner the meaning or interpretation
of this Agreement. Whenever the context requires, references to the singular shall include the plural and the plural the singular. References
to one gender include both genders.
14.15 Counterparts.
This Agreement may be executed in any number of counterparts, each of which shall be deemed an original of this Agreement, but all of
which together shall constitute one and the same instrument.
EXECUTIVE ACKNOWLEDGEMENT.
The Executive acknowledges (i) that she has consulted with or has had the opportunity to consult with independent counsel of his own choice
concerning this Agreement and has been advised to do so by the Company, and (ii) that she has read and understands the Agreement, is fully
aware of its legal effect, and has entered into it freely based on his own judgment. The Executive hereby agrees that his obligations
set forth in Sections 7, 8, and 9 hereof and the definitions of Proprietary Information and Inventions contained therein shall be equally
applicable to Proprietary Information and Inventions relating to any work performed by the Executive for the Company prior to the execution
of this Agreement.
The parties have duly executed this Agreement as
of the date first written above.
|
EXECUTIVE: |
|
|
|
|
/s/ Yaobin Wang |
|
Name: |
Yaobin Wang |
|
|
|
|
COMPANY: |
|
|
|
|
Takung Art Co., Ltd |
|
|
|
|
By: |
/s/ Kuangtao Wang |
|
Name: |
Kuangtao Wang |
|
Title: |
Chief Executive Officer |
9
v3.23.2
Cover
|
Jul. 10, 2023 |
Cover [Abstract] |
|
Document Type |
8-K
|
Amendment Flag |
false
|
Document Period End Date |
Jul. 10, 2023
|
Entity File Number |
001-38036
|
Entity Registrant Name |
TAKUNG ART CO., LTD
|
Entity Central Index Key |
0001491487
|
Entity Tax Identification Number |
26-4731758
|
Entity Incorporation, State or Country Code |
DE
|
Entity Address, Address Line One |
Office
Q 11th Floor
|
Entity Address, Address Line Two |
Kings
Wing Plaza 2
|
Entity Address, Address Line Three |
No. 1 Kwan Street
|
Entity Address, City or Town |
Sha Tin
|
Entity Address, Country |
HK
|
Entity Address, Postal Zip Code |
00000
|
City Area Code |
86
|
Local Phone Number |
13020144962
|
Written Communications |
false
|
Soliciting Material |
false
|
Pre-commencement Tender Offer |
false
|
Pre-commencement Issuer Tender Offer |
false
|
Title of 12(b) Security |
Common Stock, par value $0.001 per share
|
Trading Symbol |
TKAT
|
Security Exchange Name |
NYSEAMER
|
Entity Emerging Growth Company |
false
|
X |
- DefinitionBoolean flag that is true when the XBRL content amends previously-filed or accepted submission.
+ References
+ Details
Name: |
dei_AmendmentFlag |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionFor the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.
+ References
+ Details
Name: |
dei_DocumentPeriodEndDate |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:dateItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
+ References
+ Details
Name: |
dei_DocumentType |
Namespace Prefix: |
dei_ |
Data Type: |
dei:submissionTypeItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAddress Line 1 such as Attn, Building Name, Street Name
+ References
+ Details
Name: |
dei_EntityAddressAddressLine1 |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAddress Line 2 such as Street or Suite number
+ References
+ Details
Name: |
dei_EntityAddressAddressLine2 |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAddress Line 3 such as an Office Park
+ References
+ Details
Name: |
dei_EntityAddressAddressLine3 |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- Definition
+ References
+ Details
Name: |
dei_EntityAddressCityOrTown |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionISO 3166-1 alpha-2 country code.
+ References
+ Details
Name: |
dei_EntityAddressCountry |
Namespace Prefix: |
dei_ |
Data Type: |
dei:countryCodeItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionCode for the postal or zip code
+ References
+ Details
Name: |
dei_EntityAddressPostalZipCode |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionA unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityCentralIndexKey |
Namespace Prefix: |
dei_ |
Data Type: |
dei:centralIndexKeyItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionIndicate if registrant meets the emerging growth company criteria.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityEmergingGrowthCompany |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionCommission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.
+ References
+ Details
Name: |
dei_EntityFileNumber |
Namespace Prefix: |
dei_ |
Data Type: |
dei:fileNumberItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTwo-character EDGAR code representing the state or country of incorporation.
+ References
+ Details
Name: |
dei_EntityIncorporationStateCountryCode |
Namespace Prefix: |
dei_ |
Data Type: |
dei:edgarStateCountryItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityRegistrantName |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityTaxIdentificationNumber |
Namespace Prefix: |
dei_ |
Data Type: |
dei:employerIdItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionLocal phone number for entity.
+ References
+ Details
Name: |
dei_LocalPhoneNumber |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 13e -Subsection 4c
+ Details
Name: |
dei_PreCommencementIssuerTenderOffer |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 14d -Subsection 2b
+ Details
Name: |
dei_PreCommencementTenderOffer |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTitle of a 12(b) registered security.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b
+ Details
Name: |
dei_Security12bTitle |
Namespace Prefix: |
dei_ |
Data Type: |
dei:securityTitleItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionName of the Exchange on which a security is registered.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection d1-1
+ Details
Name: |
dei_SecurityExchangeName |
Namespace Prefix: |
dei_ |
Data Type: |
dei:edgarExchangeCodeItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Section 14a -Number 240 -Subsection 12
+ Details
Name: |
dei_SolicitingMaterial |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTrading symbol of an instrument as listed on an exchange.
+ References
+ Details
Name: |
dei_TradingSymbol |
Namespace Prefix: |
dei_ |
Data Type: |
dei:tradingSymbolItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Securities Act -Number 230 -Section 425
+ Details
Name: |
dei_WrittenCommunications |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
Takung Art (AMEX:TKAT)
Historical Stock Chart
From Jul 2024 to Aug 2024
Takung Art (AMEX:TKAT)
Historical Stock Chart
From Aug 2023 to Aug 2024